Válogatott publikációk

  1. Cooke CB, Krenács L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES. Hepatosplenic T cell lymphoma. distinct clinicopathologic entity of cytotoxic gd origin. Blood 88: 4265-4274 (1996) IF: 9,745


  1. Wellmann A, Krenács L, Fest T, Scherf U, Pastan I, Raffeld M, Brinkmann U. Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms. Am J Pathol 150: 25-29 (1997) IF: 6,501


  1. Krenács L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin’s disease. evidence for distinct cellular origin. Blood 89: 980-989 (1997) IF: 9,507


  1. Krenács L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in reactive B-cells and in subsets of B-cell lymphomas. Blood 92: 1317-1323 (1998) IF: 8,372


  1. Krenács L, Smyth MJ, Bagdi E, Krenács T, Kopper L, Rüdiger T, Zettl A, Müller-Hermelink HK, Jaffe ES, Raffeld M. The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell and intestinal T-cell lymphomas. evidence of origin from lymphocytes involved in innate immunity. Blood 101: 3590-3593 (2003) IF: 10,120


  1. Jaffe ES, Krenács L, Raffeld M. Classification of Cytotoxic T-cell and NK-cell Lymphomas. Semin Hematol 40: 175-184 (2003) IF: 3,719


  1. Glud SZ, Sorensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenács L, Stelkovics É, Wabl M, Serfling E, Palmetshofer A, Pedersen FS. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106: 3546-3552 (2005) IF: 10,131


  1. Krenács L, Schaerli P, Kis Gy, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood 108: 1110-1111 (2006) IF: 10,131


  1. Geissinger E, Bonzheim I, Krenács L, Roth S, Reimer P, Wilhelm M, Müller-Hermelink HK, Rüdiger T. Nodal Peripheral T-cell lymphomas correspond to distinct mature T-cell populations. J Pathol 210:172-180 (2006) IF: 6,213


  1. Akimzhanov A, Krenács L, Schlegel T, Klein-Hessling S, Bagdi E, Stelkovics E, Kondo E, Chuvpilo S, Wilke P, Avots A, Gattenlöhner S, Müller-Hermelink HK, Palmetshofer A, Serfling E. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. Am J Pathol 172:215-224 (2008). IF:5,697


  1. Szegedi A, Baráth S, Nagy G, Szodoray P, Gál M, Sipka S, Bagdi E, Banham AH, Krenács L. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion. Br J Dermatol 160:984-993 (2009). IF:4,206


  1. Zuern C, Krenács L, Starke S, Heimrich J, Palmetshofer A, Holtmann B, Sendtner M, Fischer T, Galle J, Wanner C, Seibold S. Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease. Int J Oncol 40:1079-1088 (2012). IF: 2,657


  1. Krenács L, Tóth-Lipták J, Demeter J, Piukovics K, Borbényi Z, Gogolák P, Sári E, Bagdi E. Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes. Virchows Arch 463:787-794 (2013). IF: 2,56


  1. Krenács D, Borbényi Z, Bedekovics J, Méhes G, Bagdi E, Krenács L. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas. Virchows Arch 467:345-355 (2015). IF: 2,651


  1. Krenács D, Bakos A, Török L, Kocsis L, Bagdi E, Krenács L. Neoplastic cells of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma lack the expression of follicular T-helper cell defining chemokine receptor CXCR5. Acta Derm Venereol 2016 Mar 1 [Epub ahead of print] IF: 3,621